Omar Khwaja

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Omar Khwaja

Form 4 holding Chief Medical Officer and Head of Research & Development.

Voyager Therapeutics, Inc.

Security class
Common Stock
Shares / value
120,509
Estimated value
$861,639
Report date
21 May 2021
Price
$7.15
Ownership
Direct
Form 4 holding Chief Medical Officer

WINDWARD BIO GROUP AG

Security class
Common Shares
Shares / value
642,136
Estimated value
Report date
12 Nov 2026
Price
Ownership
Direct
Form 4 holding Chief Medical Officer

WINDWARD BIO GROUP AG

Security class
Employee Share Option (Right to Buy)
Shares / value
219,030
Estimated value
Report date
12 Nov 2026
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount

Insider Reports Filed by Omar Khwaja

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .